Our comprehensive STI diagnostic portfolio offers high-sensitivity molecular solutions for the rapid detection of critical bacterial and viral pathogens, including Ureaplasma, Mycoplasma, Neisseria, Treponema, as well as a full spectrum of HSV and high-risk HPV genotypes. By utilizing advanced multiplex PCR technology, these assays enable streamlined clinical screening and precise risk stratification, empowering laboratories and healthcare providers to make confident, data-driven decisions in infection management and cervical health assessment.
